abstract |
A novel platform antibody composition is provided. The present invention provides a novel composition of a human IgG 2 antibody comprising a chelating agent. The present invention also provides novel antibody compositions that exhibit improved chemical and / or physical stability. Further, according to the composition of human IgG 2 antibody also provides methods of treating diseases and conditions, including inflammatory diseases and neoplastic disorders. [Selection figure] None |